APA (7th ed.) Citation

Suda, G., Nagasaka, A., Yamamoto, Y., Furuya, K., Kumagai, K., Kudo, M., . . . Sakamoto, N. (2017). Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus‐infected patients with renal impairment. Hepatology research, 47(11), 1127-1136. https://doi.org/10.1111/hepr.12851

Chicago Style (17th ed.) Citation

Suda, Goki, et al. "Safety and Efficacy of Daclatasvir and Asunaprevir in Hepatitis C Virus‐infected Patients with Renal Impairment." Hepatology Research 47, no. 11 (2017): 1127-1136. https://doi.org/10.1111/hepr.12851.

MLA (9th ed.) Citation

Suda, Goki, et al. "Safety and Efficacy of Daclatasvir and Asunaprevir in Hepatitis C Virus‐infected Patients with Renal Impairment." Hepatology Research, vol. 47, no. 11, 2017, pp. 1127-1136, https://doi.org/10.1111/hepr.12851.